Baidu
map
AM J PHYSIOL-RENAL 润色咨询

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY

出版年份:1997 年文章数:4271 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:10.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章,直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0<br>经验分享:投稿后5天分配审稿人,2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供,应该是看审稿人意见吧<span class="quote">183****1026暂无昵称 2020-02-18 00:00:00 发表:<br>想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~</span>, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~<span class="quote">David201514 2019-11-21 发表::<br>接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span><span class="quote">David201514 2019-11-21 00:00:00 发表:<br>2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span>, beContent=David201514 2019-11-21 发表:: 接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]
    2022-04-19 ms1000002016377873

    这个刊meta和网络药理学可以吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章,直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0<br>经验分享:投稿后5天分配审稿人,2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供,应该是看审稿人意见吧<span class="quote">183****1026暂无昵称 2020-02-18 00:00:00 发表:<br>想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~</span>, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~<span class="quote">David201514 2019-11-21 发表::<br>接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span><span class="quote">David201514 2019-11-21 00:00:00 发表:<br>2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span>, beContent=David201514 2019-11-21 发表:: 接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]
    2021-12-29 MS68862005

    俢回的流程是什么?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章,直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0<br>经验分享:投稿后5天分配审稿人,2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供,应该是看审稿人意见吧<span class="quote">183****1026暂无昵称 2020-02-18 00:00:00 发表:<br>想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~</span>, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~<span class="quote">David201514 2019-11-21 发表::<br>接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span><span class="quote">David201514 2019-11-21 00:00:00 发表:<br>2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span>, beContent=David201514 2019-11-21 发表:: 接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    审稿的流程是什么?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章,直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0<br>经验分享:投稿后5天分配审稿人,2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供,应该是看审稿人意见吧<span class="quote">183****1026暂无昵称 2020-02-18 00:00:00 发表:<br>想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~</span>, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~<span class="quote">David201514 2019-11-21 发表::<br>接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span><span class="quote">David201514 2019-11-21 00:00:00 发表:<br>2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span>, beContent=David201514 2019-11-21 发表:: 接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]
    2020-11-21 124022a9m79暂无昵称

    临床的文章,直接秒拒

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章,直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0<br>经验分享:投稿后5天分配审稿人,2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供,应该是看审稿人意见吧<span class="quote">183****1026暂无昵称 2020-02-18 00:00:00 发表:<br>想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~</span>, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~<span class="quote">David201514 2019-11-21 发表::<br>接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span><span class="quote">David201514 2019-11-21 00:00:00 发表:<br>2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span>, beContent=David201514 2019-11-21 发表:: 接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]
    2019-11-21 David201514

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章,直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0<br>经验分享:投稿后5天分配审稿人,2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供,应该是看审稿人意见吧<span class="quote">183****1026暂无昵称 2020-02-18 00:00:00 发表:<br>想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~</span>, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~<span class="quote">David201514 2019-11-21 发表::<br>接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span><span class="quote">David201514 2019-11-21 00:00:00 发表:<br>2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span>, beContent=David201514 2019-11-21 发表:: 接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]
    2020-02-10 123cda6em39(暂无昵称)

    审稿速度:1.0
    经验分享:投稿后5天分配审稿人,2周拒稿

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章,直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0<br>经验分享:投稿后5天分配审稿人,2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供,应该是看审稿人意见吧<span class="quote">183****1026暂无昵称 2020-02-18 00:00:00 发表:<br>想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~</span>, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~<span class="quote">David201514 2019-11-21 发表::<br>接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span><span class="quote">David201514 2019-11-21 00:00:00 发表:<br>2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span>, beContent=David201514 2019-11-21 发表:: 接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]
    2020-05-08 David201514

    我的没有要求提供,应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表:
    想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~

    183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章,直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0<br>经验分享:投稿后5天分配审稿人,2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供,应该是看审稿人意见吧<span class="quote">183****1026暂无昵称 2020-02-18 00:00:00 发表:<br>想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~</span>, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~<span class="quote">David201514 2019-11-21 发表::<br>接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span><span class="quote">David201514 2019-11-21 00:00:00 发表:<br>2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span>, beContent=David201514 2019-11-21 发表:: 接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]
    2020-02-18 123a6632m26暂无昵称

    想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~David201514 2019-11-21 发表::
    接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。
    David201514 2019-11-21 00:00:00 发表:
    2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。

    David201514 2019-11-21 发表:: 接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章,直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0<br>经验分享:投稿后5天分配审稿人,2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供,应该是看审稿人意见吧<span class="quote">183****1026暂无昵称 2020-02-18 00:00:00 发表:<br>想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~</span>, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~<span class="quote">David201514 2019-11-21 发表::<br>接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span><span class="quote">David201514 2019-11-21 00:00:00 发表:<br>2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span>, beContent=David201514 2019-11-21 发表:: 接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    求经验分享

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章,直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0<br>经验分享:投稿后5天分配审稿人,2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供,应该是看审稿人意见吧<span class="quote">183****1026暂无昵称 2020-02-18 00:00:00 发表:<br>想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~</span>, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下,原始数据是接收前提供还是接收后提供呀,谢谢~<span class="quote">David201514 2019-11-21 发表::<br>接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span><span class="quote">David201514 2019-11-21 00:00:00 发表:<br>2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。</span>, beContent=David201514 2019-11-21 发表:: 接收率:约25% 审稿时间:约1个月 2019.02.13提交,3月中旬一审回,中间耽搁了一下,四月中修回,五月初接收。审稿挺快的,三个审稿人,还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]
    2018-06-09 mingwunl

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快.

    0

共22条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map